HOSPITAL UNIVERSITARIO RUBER
Saila
Cancer Research UK Cambridge Institute
Cambridge, Reino UnidoCancer Research UK Cambridge Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance
Clinical Cancer Research, Vol. 28, Núm. 20, pp. 4536-4550